Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sildenafil for Asymmetrical IUGR
NCT02678221Phase 2Unknown
- Sponsor
- Assiut University
- Start
- Feb 2016
- Primary completion
- Feb 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of sildenafil in intrauterine growth restriction (IUGR), sponsored by Assiut University. Status: unknown.
02
Drugs
sildenafil
03
Conditions
intrauterine growth restriction (IUGR)
Beyond the preview
Go deeper on NCT02678221.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02678221.